申请人:LABORATOIRES SYNTEX S.A.
公开号:EP0249245A2
公开(公告)日:1987-12-16
Compounds of formula 1 as their racemic mixtures or optical isomers are calcium entry antagonists useful for treating hypertension, congestive heart failure, angina, and vasospastic disorders:
wherein n is an integer from 1 to 4; R1 and R2 are lower alkyl; R3 is lower alkyl or alkoxyalkyl; A is alkylene of two to eight carbon atoms; X1 and X2 are each independently -N02, -CF3, CH30-, -CN, -H, lower alkyl or halo; Y is -O-, -S-, -S(O)-, or -S(O)2-; and R is H or R' wherein R' is lower alkyl, cycloalkyl, alkoxyalkyl, cycloalkyloxy-alkyl, alkoxycycloalkyl, acyl, or saturated or unsaturated 5-or 6-membered heterocyclyl optionally substituted with lower alkyl or alkoxy, wherein the heteroatom is one oxygen atom.
式 1 的化合物作为其外消旋混合物或光学异构体是钙离子进入拮抗剂,可用于治疗高血压、充血性心力衰竭、心绞痛和血管痉挛性疾病:
其中 n 是 1 到 4 的整数;R1 和 R2 是低级烷基;R3 是低级烷基或烷氧基烷基;A 是 2 到 8 个碳原子的亚烷基;X1 和 X2 各自独立地是-N02、-CF3、CH30-、-CN、-H、低级烷基或卤代;Y 是-O-、-S-、-S(O)- 或-S(O)2-;R是H或R',其中R'是低级烷基、环烷基、烷氧基烷基、环烷氧基烷基、烷氧基环烷基、酰基或饱和或不饱和的5或6元杂环烷基,可任选被低级烷基或烷氧基取代,其中杂原子是一个氧原子。